Product Description: S7 is an IL-6 receptor antagonist and inhibits the binding between IL-6 and IL-6R. S7 can inhibit angiogenesis and tumor growth[1].
Applications: Cancer-programmed cell death
Formula: C37H70N10O10
References: [1]Janelle W. Salameh, et al. Targeted Interleukin-27 Gene Therapy Development for Disrupting Key Malignant Crosstalk between Metastatic Prostate Cancer and Bone.